Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sebacia
Duluth, Georgia, United Statessebacia.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Sebacia developed a novel dermatology treatment for acne using gold microparticles activated by dermatology lasers. Clinical trials demonstrated safety and effectiveness for mild to moderate inflammatory acne. The product was cleared for use in the U.S. and EU before the company dissolved. The approach offered an alternative to daily topical or systemic drugs by providing an office-based procedure performed by dermatologists.
- Therapeutic areas
- GastroenterologyDermatology
- Modalities
- DeviceNanoparticle (specifically gold microparticles)Non-pharmacological therapy (laser-based procedure)
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Sebacia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sebacia.